{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T08:27:40Z","timestamp":1771057660108,"version":"3.50.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2017,8,5]],"date-time":"2017-08-05T00:00:00Z","timestamp":1501891200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000659","name":"Research Trainees Coordinating Centre","doi-asserted-by":"publisher","award":["NIHR HEE Senior Clinical Lectureship"],"award-info":[{"award-number":["NIHR HEE Senior Clinical Lectureship"]}],"id":[{"id":"10.13039\/501100000659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetologia"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1007\/s00125-017-4383-3","type":"journal-article","created":{"date-parts":[[2017,8,4]],"date-time":"2017-08-04T18:38:54Z","timestamp":1501871934000},"page":"2168-2173","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Screening for neonatal diabetes at day 5 of life using dried blood spot glucose measurement"],"prefix":"10.1007","volume":"60","author":[{"given":"Timothy J.","family":"McDonald","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel E.","family":"Besser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mandy","family":"Perry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tarig","family":"Babiker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bridget A.","family":"Knight","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maggie H.","family":"Shepherd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sian","family":"Ellard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah E.","family":"Flanagan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew T.","family":"Hattersley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,8,5]]},"reference":[{"key":"4383_CR1","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1007\/s00125-009-1416-6","volume":"52","author":"AS Slingerland","year":"2009","unstructured":"Slingerland AS, Shields BM, Flanagan SE et al (2009) Referral rates for diagnostic testing support an incidence of permanent neonatal diabetes in three European countries of at least 1 in 260,000 live births. Diabetologia 52:1683\u20131685","journal-title":"Diabetologia"},{"key":"4383_CR2","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/j.1399-5448.2009.00530.x","volume":"11","author":"B Wiedemann","year":"2010","unstructured":"Wiedemann B, Schober E, Waldhoer T et al (2010) Incidence of neonatal diabetes in Austria-calculation based on the Austrian diabetes register. Pediatr Diabetes 11:18\u201323","journal-title":"Pediatr Diabetes"},{"key":"4383_CR3","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s00592-011-0331-8","volume":"49","author":"D Iafusco","year":"2012","unstructured":"Iafusco D, Massa O, Pasquino B et al (2012) Minimal incidence of neonatal\/infancy onset diabetes in Italy is 1:90,000 live births. Acta Diabetol 49:405\u2013408","journal-title":"Acta Diabetol"},{"key":"4383_CR4","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/S0140-6736(15)60098-8","volume":"386","author":"E Franco De","year":"2015","unstructured":"De Franco E, Flanagan SE, Houghton JA et al (2015) The effect of early, comprehensive genomic testing on clinical care in neonatal diabetes: an international cohort study. Lancet 386:957\u2013963","journal-title":"Lancet"},{"key":"4383_CR5","doi-asserted-by":"crossref","first-page":"15040","DOI":"10.1073\/pnas.0707291104","volume":"104","author":"J Stoy","year":"2007","unstructured":"Stoy J, Edghill EL, Flanagan SE et al (2007) Insulin gene mutations as a cause of permanent neonatal diabetes. Proc Natl Acad Sci U S A 104:15040\u201315044","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4383_CR6","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1056\/NEJMoa055068","volume":"355","author":"AP Babenko","year":"2006","unstructured":"Babenko AP, Polak M, Cave H et al (2006) Activating mutations in the ABCC8 gene in neonatal diabetes mellitus. N Engl J Med 355:456\u2013466","journal-title":"N Engl J Med"},{"key":"4383_CR7","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1056\/NEJMoa032922","volume":"350","author":"AL Gloyn","year":"2004","unstructured":"Gloyn AL, Pearson ER, Antcliff JF et al (2004) Activating mutations in the gene encoding the ATP-sensitive potassium-channel subunit Kir6.2 and permanent neonatal diabetes. N Engl J Med 350:1838\u20131849","journal-title":"N Engl J Med"},{"key":"4383_CR8","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1056\/NEJMoa061759","volume":"355","author":"ER Pearson","year":"2006","unstructured":"Pearson ER, Flechtner I, Njolstad PR et al (2006) Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations. N Engl J Med 355:467\u2013477","journal-title":"N Engl J Med"},{"key":"4383_CR9","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1038\/sj.ejhg.5201629","volume":"14","author":"AL Gloyn","year":"2006","unstructured":"Gloyn AL, Diatloff-Zito C, Edghill EL et al (2006) KCNJ11 activating mutations are associated with developmental delay, epilepsy and neonatal diabetes syndrome and other neurological features. Eur J Hum Genet 14:824\u2013830","journal-title":"Eur J Hum Genet"},{"key":"4383_CR10","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1159\/000360004","volume":"82","author":"K Busiah","year":"2014","unstructured":"Busiah K, Verkarre V, Cave H, Scharfmann R, Polak M (2014) Human pancreas endocrine cell populations and activating ABCC8 mutations. Horm Res Paediatr 82:59\u201364","journal-title":"Horm Res Paediatr"},{"key":"4383_CR11","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1002\/pdi.1385","volume":"26","author":"B Jose","year":"2009","unstructured":"Jose B, Griffiths U, Barrett T, Hattersley AT, Milles JJ (2009) Glibenclamide controls ketosis-prone diabetes in a 38-year-old woman with Kir6.2 mutation. Pract Diabetes Int 26:244\u2013245","journal-title":"Pract Diabetes Int"},{"key":"4383_CR12","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1111\/dme.13328","volume":"34","author":"JO Day","year":"2017","unstructured":"Day JO, Flanagan SE, Shepherd MH et al (2017) Hyperglycaemia-related complications at the time of diagnosis can cause permanent neurological disability in children with neonatal diabetes. Diabet Med 34:1000\u20131004","journal-title":"Diabet Med"},{"key":"4383_CR13","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.2337\/diabetes.54.9.2503","volume":"54","author":"AT Hattersley","year":"2005","unstructured":"Hattersley AT, Ashcroft FM (2005) Activating mutations in Kir6.2 and neonatal diabetes: new clinical syndromes, new scientific insights, and new therapy. Diabetes 54:2503\u20132513","journal-title":"Diabetes"},{"key":"4383_CR14","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1053\/j.semperi.2015.03.002","volume":"39","author":"BL Therrell","year":"2015","unstructured":"Therrell BL, Padilla CD, Loeber JG et al (2015) Current status of newborn screening worldwide: 2015. Semin Perinatol 39:171\u2013187","journal-title":"Semin Perinatol"},{"key":"4383_CR15","unstructured":"Public Health England (2012). Newborn blood spot screening programme. Available from \nhttp:\/\/www.gov.uk\/government\/collections\/newborn-blood-spot-screening-programme-supporting-publications\n\n. Accessed July 2017"},{"key":"4383_CR16","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/j.1365-3016.2006.00701.x","volume":"20","author":"B Knight","year":"2006","unstructured":"Knight B, Shields BM, Hattersley AT (2006) The Exeter family study of childhood health (EFSOCH): study protocol and methodology. Paediatr Perinat Epidemiol 20:172\u2013179","journal-title":"Paediatr Perinat Epidemiol"},{"key":"4383_CR17","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.earlhumdev.2005.05.006","volume":"82","author":"BM Shields","year":"2006","unstructured":"Shields BM, Knight B, Shakespeare L et al (2006) Determinants of insulin concentrations in healthy 1-week-old babies in the community: applications of a bloodspot assay. Early Hum Dev 82:143\u2013148","journal-title":"Early Hum Dev"},{"key":"4383_CR18","first-page":"281","volume":"65","author":"JM Wilson","year":"1968","unstructured":"Wilson JM, Jungner YG (1968) Principles and practice of mass screening for disease. Bol Oficina Sanit Panam 65:281\u2013393","journal-title":"Bol Oficina Sanit Panam"},{"key":"4383_CR19","unstructured":"Public Health England (2013) Criteria for appraising the viability, effectiveness and appropriateness of a screening programme. Available from \nhttp:\/\/www.gov.uk\/government\/publications\/evidence-review-criteria-national-screening-programmes\/criteria-for-appraising-the-viability-effectiveness-and-appropriateness-of-a-screening-programme\n\n. Accessed July 2017"},{"key":"4383_CR20","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S2213-8587(13)70059-7","volume":"1","author":"K Busiah","year":"2013","unstructured":"Busiah K, Drunat S, Vaivre-Douret L et al (2013) Neuropsychological dysfunction and developmental defects associated with genetic changes in infants with neonatal diabetes mellitus: a prospective cohort study [corrected]. Lancet Diabetes Endocrinol 1:199\u2013207","journal-title":"Lancet Diabetes Endocrinol"}],"container-title":["Diabetologia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00125-017-4383-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-017-4383-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-017-4383-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,9,27]],"date-time":"2017-09-27T06:28:19Z","timestamp":1506493699000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00125-017-4383-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,5]]},"references-count":20,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["4383"],"URL":"https:\/\/doi.org\/10.1007\/s00125-017-4383-3","relation":{},"ISSN":["0012-186X","1432-0428"],"issn-type":[{"value":"0012-186X","type":"print"},{"value":"1432-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,5]]}}}